What Two Sigma Advisers LP changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$0
$7.0bn at Q2 2013
Positions
0
2,136 at Q2 2013
Top ten weight
n.a.
19% at Q2 2013
Typical quarterly turnover
about 26%
Estimated from share changes
- Q2 2013: $7.0bn
- Q3 2013: $8.4bn
- Q4 2013: $10.4bn
- Q1 2014: $11.0bn
- Q2 2014: $12.8bn
- Q3 2014: $13.3bn
- Q4 2014: $12.9bn
- Q1 2015: $13.6bn
- Q2 2015: $13.4bn
- Q3 2015: $15.9bn
- Q4 2015: $16.8bn
- Q1 2016: $17.9bn
- Q2 2016: $19.7bn
- Q3 2016: $23.5bn
- Q4 2016: $26.1bn
- Q1 2017: $30.5bn
- Q2 2017: $30.3bn
- Q3 2017: $35.3bn
- Q4 2017: $37.1bn
- Q1 2018: $36.9bn
- Q2 2018: $37.2bn
- Q3 2018: $41.0bn
- Q4 2018: $36.6bn
- Q1 2019: $39.7bn
- Q2 2019: $40.2bn
- Q3 2019: $40.9bn
- Q4 2019: $43.1bn
- Q1 2020: $26.1bn
- Q2 2020: $34.0bn
- Q3 2020: $35.0bn
- Q4 2020: $37.4bn
- Q1 2021: $36.4bn
- Q2 2021: $37.9bn
- Q3 2021: $38.6bn
- Q4 2021: $39.9bn
- Q1 2022: $37.6bn
- Q2 2022: $35.3bn
- Q3 2022: $34.5bn
- Q4 2022: $35.8bn
- Q1 2023: $38.8bn
- Q2 2023: $39.3bn
- Q3 2023: $39.0bn
- Q4 2023: $42.7bn
- Q1 2024: $43.2bn
- Q2 2024: $44.8bn
- Q3 2024: $42.7bn
- Q4 2024: $43.2bn
- Q1 2025: $44.4bn
- Q2 2025: $48.8bn
- Q3 2025: $50.0bn
- Q4 2025: $51.4bn
- Q1 2026: $0
- Q2 2026: $0
- Q2 2013: 19%
- Q3 2013: 14%
- Q4 2013: 14%
- Q1 2014: 13%
- Q2 2014: 13%
- Q3 2014: 10%
- Q4 2014: 10%
- Q1 2015: 9%
- Q2 2015: 9%
- Q3 2015: 9%
- Q4 2015: 10%
- Q1 2016: 11%
- Q2 2016: 12%
- Q3 2016: 10%
- Q4 2016: 9%
- Q1 2017: 9%
- Q2 2017: 10%
- Q3 2017: 10%
- Q4 2017: 9%
- Q1 2018: 8%
- Q2 2018: 9%
- Q3 2018: 10%
- Q4 2018: 10%
- Q1 2019: 10%
- Q2 2019: 11%
- Q3 2019: 12%
- Q4 2019: 12%
- Q1 2020: 12%
- Q2 2020: 14%
- Q3 2020: 13%
- Q4 2020: 12%
- Q1 2021: 14%
- Q2 2021: 13%
- Q3 2021: 13%
- Q4 2021: 13%
- Q1 2022: 14%
- Q2 2022: 13%
- Q3 2022: 14%
- Q4 2022: 14%
- Q1 2023: 12%
- Q2 2023: 14%
- Q3 2023: 16%
- Q4 2023: 17%
- Q1 2024: 17%
- Q2 2024: 18%
- Q3 2024: 17%
- Q4 2024: 20%
- Q1 2025: 18%
- Q2 2025: 19%
- Q3 2025: 19%
- Q4 2025: 19%
- Q1 2026: 0%
- Q2 2026: 0%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q3 2016 | $1.7bnQ4 2025 | Soldlast listed Q4 2025 | |
| Apple Inc(AAPL) | Q3 2013 | $1.6bnQ4 2025 | Soldlast listed Q4 2025 | |
| Microsoft Corp(MSFT) | Q3 2014 | $1.5bnQ3 2025 | Soldlast listed Q4 2025 | |
| Amazon Com Inc(AMZN) | Q1 2015 | $1.1bnQ4 2025 | Soldlast listed Q4 2025 | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q4 2015 | $801mQ2 2025 | Soldlast listed Q4 2025 | |
| JPMorgan Chase & Co(JPM) | Q2 2013 | $769mQ3 2025 | Soldlast listed Q4 2025 | |
| Facebook Inc A(META)Class A | Q3 2014 | $726mQ4 2024 | Soldlast listed Q4 2025 | |
| Mastercard Inc(MA)Class A | Q3 2014 | $701mQ4 2025 | Soldlast listed Q4 2025 |
Quarter by quarter
Q1 2016: $17.9bn across 2,020 positions
Against Q4 2015: 430 new, 820 added to, 747 trimmed, 242 sold out, across all 2,020 positions.
Turnover about 23% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Gilead Sciences Inc (GILD)+$145m
- Motorola Solutions Inc (MSI)+$92m
- McDonald's Corp (MCD)+$84m
- Alphabet Inc (GOOGL)+$74m
- Teva Pharmaceutical Inds LTD (TEVA)+$71m
- Mastercard Inc (MA)+$69m
- Cognizant Technology Solutio (CTSH)+$67m
- Amazon Com Inc (AMZN)+$62m
Largest reductions
- Spdr S&P 500 Etf Trust (SPY)-$136m
- Verizon Communications Inc (VZ)-$119m
- Union Pac Corp (UNP)-$106m
- International Business Machs (IBM)-$99m
- Schlumberger LTD (SLB)-$96m
- Target Corp (TGT)-$90m
- Biogen Idec Inc (BIIB)-$81m
- Merck & Co Inc New (MRK)-$72m
Opened
Nothing new among the largest positions.
Sold out
- Broadcom Corpwas $122m
- Avago Technologies LTDwas $116m
- Towers Watson & Cowas $67m
- Willis Group Holdings Publicwas $62m
- Chubb Corpwas $39m
- Health Net Incwas $39m
- Sirona Dental Systems Incwas $35m
- Palo Alto Networks Inc (PANW)was $35m
Largest positions, Q1 2016
The largest 25 of 2,020 reported positions; the largest 500 carry 89.7% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Home Depot Inc (HD) | $220m | 1.2% | Added |
| Time Warner Cable Inc | $196m | 1.1% | Added |
| Dow Chem Co | $195m | 1.1% | Added |
| Du Pont E I de Nemours & Co | $194m | 1.1% | Added |
| Pfizer Inc (PFE) | $192m | 1.1% | Added |
| Pepsico Inc (PEP) | $191m | 1.1% | Added |
| Gilead Sciences Inc (GILD) | $191m | 1.1% | Added |
| Allergan PLC | $188m | 1.0% | Added |
| Charter Communication A | $173m | 1.0% | Added |
| Abbvie Inc (ABBV) | $168m | 0.9% | Added |
| Starwood Hotels&resorts WRLD | $156m | 0.9% | Added |
| Colgate Palmolive Co (CL) | $152m | 0.9% | Added |
| Constellation Brands Inc (STZ) | $151m | 0.8% | Added |
| Regeneron Pharmaceuticals (REGN) | $145m | 0.8% | Added |
| Applied Matls Inc (AMAT) | $143m | 0.8% | Trimmed |
| Air Prods & Chems Inc (APD) | $143m | 0.8% | Added |
| Halliburton Co (HAL) | $143m | 0.8% | Trimmed |
| Amazon Com Inc (AMZN) | $140m | 0.8% | Added |
| Qualcomm Inc (QCOM) | $140m | 0.8% | Added |
| Expedia Inc Del (EXPE) | $132m | 0.7% | Added |
| Western Digital Corp (WDC) | $130m | 0.7% | Added |
| NIKE Inc (NKE) | $129m | 0.7% | Trimmed |
| CBS Corp New | $128m | 0.7% | Trimmed |
| Eaton Corp PLC (ETN) | $127m | 0.7% | Trimmed |
| Marriott Intl Inc New (MAR) | $127m | 0.7% | Added |
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Two Sigma Advisers LP | $0 | 13F-HR | |
| Q1 2026 | Two Sigma Advisers LP | $0 | 13F-HR | |
| Q4 2025 | Two Sigma Advisers LP | $51.4bn | 13F-HR | |
| Q3 2025 | Two Sigma Advisers LP | $50.0bn | 13F-HR | |
| Q2 2025 | Two Sigma Advisers LP | $48.8bn | 13F-HR | |
| Q1 2025 | Two Sigma Advisers LP | $44.4bn | 13F-HR | |
| Q4 2024 | Two Sigma Advisers LP | $43.2bn | 13F-HR | |
| Q3 2024 | Two Sigma Advisers LP | $42.7bn | 13F-HR | |
| Q2 2024 | Two Sigma Advisers LP | $44.8bn | 13F-HR | |
| Q1 2024 | Two Sigma Advisers LP | $43.2bn | 13F-HR | |
| Q4 2023 | Two Sigma Advisers LP | $42.7bn | 13F-HR | |
| Q3 2023 | Two Sigma Advisers LP | $39.0bn | 13F-HR | |
| Q2 2023 | Two Sigma Advisers LP | $39.3bn | 13F-HR | |
| Q1 2023 | Two Sigma Advisers LP | $38.8bn | 13F-HR | |
| Q4 2022 | Two Sigma Advisers LP | $35.8bn | 13F-HR | |
| Q3 2022 | Two Sigma Advisers LP | $34.5bn | 13F-HR | |
| Q2 2022 | Two Sigma Advisers LP | $35.3bn | 13F-HR | |
| Q1 2022 | Two Sigma Advisers LP | $37.6bn | 13F-HR | |
| Q4 2021 | Two Sigma Advisers LP | $39.9bn | 13F-HR | |
| Q3 2021 | Two Sigma Advisers LP | $38.6bn | 13F-HR | |
| Q2 2021 | Two Sigma Advisers LP | $37.9bn | 13F-HR | |
| Q1 2021 | Two Sigma Advisers LP | $36.4bn | 13F-HR | |
| Q4 2020 | Two Sigma Advisers LP | $37.4bn | 13F-HR | |
| Q3 2020 | Two Sigma Advisers LP | $35.0bn | 13F-HR | |
| Q2 2020 | Two Sigma Advisers LP | $34.0bn | 13F-HR | |
| Q1 2020 | Two Sigma Advisers LP | $26.1bn | 13F-HR | |
| Q4 2019 | Two Sigma Advisers LP | $43.1bn | 13F-HR | |
| Q3 2019 | Two Sigma Advisers LP | $40.9bn | 13F-HR | |
| Q2 2019 | Two Sigma Advisers LP | $40.2bn | 13F-HR | |
| Q1 2019 | Two Sigma Advisers LP | $39.7bn | 13F-HR | |
| Q4 2018 | Two Sigma Advisers LP | $36.6bn | 13F-HR | |
| Q3 2018 | Two Sigma Advisers LP | $41.0bn | 13F-HR | |
| Q2 2018 | Two Sigma Advisers LP | $37.2bn | 13F-HR | |
| Q1 2018 | Two Sigma Advisers LP | $36.9bn | 13F-HR | |
| Q4 2017 | Two Sigma Advisers LP | $37.1bn | 13F-HR | |
| Q3 2017 | Two Sigma Advisers LP | $35.3bn | 13F-HR | |
| Q2 2017 | Two Sigma Advisers LP | $30.3bn | 13F-HR | |
| Q1 2017 | Two Sigma Advisers LP | $30.5bn | 13F-HR | |
| Q4 2016 | Two Sigma Advisers LP | $26.1bn | 13F-HR | |
| Q3 2016 | Two Sigma Advisers LP | $23.5bn | 13F-HR | |
| Q2 2016 | Two Sigma Advisers LP | $19.7bn | 13F-HR | |
| Q1 2016 | Two Sigma Advisers LP | $17.9bn | 13F-HR | |
| Q4 2015 | Two Sigma Advisers LP | $16.8bn | 13F-HR | |
| Q3 2015 | Two Sigma Advisers LP | $15.9bn | 13F-HR | |
| Q2 2015 | Two Sigma Advisers LP | $13.4bn | 1 | 13F-HR |
| Q1 2015 | Two Sigma Advisers LP | $13.6bn | 1 | 13F-HR |
| Q4 2014 | Two Sigma Advisers LP | $12.9bn | 1 | 13F-HR |
| Q3 2014 | Two Sigma Advisers LP | $13.3bn | 1 | 13F-HR |
| Q2 2014 | Two Sigma Advisers LP | $12.8bn | 1 | 13F-HR |
| Q1 2014 | Two Sigma Advisers LP | $11.0bn | 13F-HR | |
| Q4 2013 | Two Sigma Advisers LP | $10.4bn | 13F-HR | |
| Q3 2013 | Two Sigma Advisers LP | $8.4bn | 13F-HR | |
| Q2 2013 | Two Sigma Advisers LP | $7.0bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More